Wolfram Pönisch

ORCID

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 4

Top Venues

Journal of cancer research and clinical oncology

EJHaem

This page only lists publications with an associated author ORCID identifier.

Publications

Tanja Holzhey, Wolfram Pönisch, Song-Yau Wang, Madlen Holzvogt, Bruno Holzvogt, Marc Andrea, Thomas Zehrfeld, Doreen Hammerschmidt, Franz Albert Hoffmann, Cornelia Becker, Andreas Schwarzer, Maik Schwarz, Uta Schönfelder-Fricke, Thomas Edelmann, Leanthe Braunert, Georg-Nikolaus Franke, Madlen Jentzsch, Sebastian Schwind, Markus Bill, Juliane Grimm, Yvonne Remane, Uwe Platzbecker, Markus Scholz
Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV). Journal of cancer research and clinical oncology 147 (8) (2021)
Heinz Ludwig, Bela Hausmann, Martin Schreder, Wolfram Pönisch, Niklas Zojer, Stefan Knop, Eberhard Gunsilius, Alexander Egle, Andreas Petzer, Hermann Einsele, Roman Hájek, Katja Weisel, Karl Jochen Krenosz, Alois Lang, Daniel Lechner, Richard Greil, David Berry
Reduced alpha diversity of the oral microbiome correlates with short progression-free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib-based therapy (AGMT MM 1, phase II trial). EJHaem 2 (1) (2020)
Hannah Tessenow, Madlen Holzvogt, Bruno Holzvogt, Marc Andrea, Simone Heyn, Thomas Schliwa, Maik Schwarz, Thomas Zehrfeld, Cornelia Becker, Christian Pfrepper, Georg Nikolaus Franke, Rainer Krahl, Madlen Jentzsch, Sabine Leiblein, Sebastian Schwind, Marius Bill, Vladan Vucinic, Thoralf Lange, Dietger Niederwieser, Wolfram Pönisch
Successful treatment of patients with newly diagnosed/untreated light chain multiple myeloma with a combination of bendamustine, prednisone and bortezomib (BPV). Journal of cancer research and clinical oncology 143 (10) (2017)
Juliane Beck, Andreas Schwarzer, Dietrich Gläser, Lars-Olof Mügge, Jens Uhlig, Simone Heyn, Brigitte Kragl, Martin Mohren, Franz Albert Hoffmann, Thoralf Lange, Thomas Schliwa, Thomas Zehrfeld, Cornelia Becker, Ute Kreibich, Cornelia Winkelmann, Thomas Edelmann, Marc Andrea, Marius Bill, Madlen Jentzsch, Sebastian Schwind, Dietger Niederwieser, Wolfram Pönisch
Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077). Journal of cancer research and clinical oncology 143 (12) (2017)

Wolfram Pönisch.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Wolfram Pönisch